Oh Young Jung
Primary Care · Buford, GANPI 1811664782
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 137 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 29 manufacturers, the largest accounting for just 19.7% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $959 and has fallen 92.4% since, to $73 in 2025.
Across 137 payments — averaging $18.03 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$485
- AstraZeneca$473
- AbbVie$242
- Paratek Pharmaceuticals, Inc.$194
- Amgen$177
- Lilly USA, LLC$99
- plus $799 from 23 others
What the payments were for
- Food & beverage$2,470100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 36 | $485 |
| AstraZeneca | 22 | $473 |
| AbbVie | 8 | $242 |
| Paratek Pharmaceuticals, Inc. | 10 | $194 |
| Amgen | 11 | $177 |
| Lilly USA, LLC | 6 | $99 |
| Kowa Pharmaceuticals America, Inc. | 6 | $96 |
| Revance Therapeutics, Inc. | 1 | $73 |
| GSK | 5 | $66 |
| Pfizer | 3 | $66 |
| Astellas Pharma US Inc | 4 | $59 |
| Hikma Pharmaceuticals USA | 3 | $43 |
| Scilex Pharmaceuticals Inc. | 2 | $43 |
| Amarin Pharma, Inc. | 2 | $43 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $41 |
| Lundbeck LLC | 2 | $36 |
| Exact Sciences | 2 | $32 |
| Dexcom, Inc. | 1 | $26 |
| Johnson & Johnson | 1 | $24 |
| IBSA Pharma Inc. | 1 | $20 |
| Nestle Healthcare Nutrition Inc. | 1 | $17 |
| Esperion Therapeutics, Inc. | 1 | $16 |
| Merck | 1 | $15 |
| Novartis | 1 | $15 |
| Eisai Inc. | 1 | $15 |
| Boehringer Ingelheim | 1 | $14 |
| Ironwood Pharmaceuticals, Inc | 1 | $14 |
| Eyevance Pharmaceuticals LLC | 1 | $14 |
| Cequr Corporation | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,470 in reported general payments places this provider in the 80th percentile of 235 primary care providers in Georgia.
Other primary care in Buford
- Pamela TurkDouglas$15K
- Morgan JonesLawrenceville$14K
- Jessi HaleColumbus$13K
- Meredith CarrAugusta$12K
- Ashtyn ZaryckiSavannah$12K
- Zanetta BryantNewnan$11K
- Hannah CummingsSuwanee$9K
- Michelle LadewigGainesville$7K
- Lucia OcanoviciuCanton$7K
- Sarah NewGrovetown$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.